Immunocore Holdings plc (IMCR) Tops Q3 EPS by 50c

Immunocore Holdings plc (NASDAQ: IMCR) reported Q3 EPS of $0.17, $0.50 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $80.25 million versus the consensus estimate of $78.88 million.

For earnings history and earnings-related data on Immunocore Holdings plc (IMCR) click here.

You May Also Be Interested In

• Wolfe forecasts August payrolls growth of 65k ahead of September FOMC
• SCHMID Group cuts profit margin outlook, keeps revenue target above €100M
• NuScale adopts AI tools from Nuclearn and NPX for reactor program